GSK3B and neoplasm: Therefore, targeting of GSK3β in musculoskeletal tumors may have three advantages: direct therapeutic effect against the tumor, reduction of normal tissue defect caused by surgical removal of the tumor, and enhancement of adjacent normal tissue preservation.